AI meets Biophysics for Drug Discovery
Cyclica is a Toronto-based biotechnology company that leverages biophysics and artificial intelligence (AI) to make drug discovery faster, safer, and cheaper. We enable all scientists in Pharma with an integrated network of technologies, thereby driving drug discovery and revolutionizing a system troubled with attrition and costly failures.
Our cloud-based Ligand Express™ platform uncovers the polypharmacological profiles of small molecules to provide insights into target identification, drug repurposing, lead prioritization, and adverse effect elucidation. We are extending the capabilities of Ligand Express™ with an innovation that layers annotated genetic data onto a protein’s structure using our structural pharmacogenomics technology. Also making its way into Ligand Express is our ADMET Prediction tool, an adaptive AI modelling methodology, which outperforms traditional classifiers for generating QSAR models in our benchmarking studies.
See what the market is saying about us: